-
1
-
-
0036772381
-
The spectrum of congenital myasthenic syndromes
-
Engel AG, Ohno K, Sine SM. The spectrum of congenital myasthenic syndromes. Mol Neurobiol 2002;26:347-367.
-
(2002)
Mol Neurobiol
, vol.26
, pp. 347-367
-
-
Engel, A.G.1
Ohno, K.2
Sine, S.M.3
-
2
-
-
0032103142
-
Quinidine normalizes the open duration of slow-channel mutants of the acetylcholine receptor
-
Fukudome T, Ohno K, Brengman JM, Engel AG. Quinidine normalizes the open duration of slow-channel mutants of the acetylcholine receptor. Neuroreport 1998;9:1907-1911.
-
(1998)
Neuroreport
, vol.9
, pp. 1907-1911
-
-
Fukudome, T.1
Ohno, K.2
Brengman, J.M.3
Engel, A.G.4
-
3
-
-
0031749640
-
Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome
-
Harper CM, Engel AG. Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome. Ann Neurol 1998;43:480-484.
-
(1998)
Ann Neurol
, vol.43
, pp. 480-484
-
-
Harper, C.M.1
Engel, A.G.2
-
4
-
-
0030749730
-
Nicotinic acetylcholine antagonist effect of fluoxetine in rat hippocampal slices
-
Hennings ECP, Kiss JP, Vizi ES, Nicotinic acetylcholine antagonist effect of fluoxetine in rat hippocampal slices. Brain Res 1997;759:292-294.
-
(1997)
Brain Res
, vol.759
, pp. 292-294
-
-
Hennings, E.C.P.1
Kiss, J.P.2
Vizi, E.S.3
-
5
-
-
0031048599
-
Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)
-
Garcia-Colunga J, Awad JN, Miledi R. Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac). Proc Natl Acad Sci USA 1997;94:2041-2044.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 2041-2044
-
-
Garcia-Colunga, J.1
Awad, J.N.2
Miledi, R.3
-
6
-
-
0025764532
-
The Rochester Diabetic Neuropathy Study: Design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests
-
Dyck PJ, Kratz KM, Lehman KA, et al. The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991;45:799-807.
-
(1991)
Neurology
, vol.45
, pp. 799-807
-
-
Dyck, P.J.1
Kratz, K.M.2
Lehman, K.A.3
-
7
-
-
0024367939
-
3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome
-
McEvoy KM, Windebank AJ, Daube JR, Low PA. 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. N Engl J Med 1989;321:1567-1571.
-
(1989)
N Engl J Med
, vol.321
, pp. 1567-1571
-
-
McEvoy, K.M.1
Windebank, A.J.2
Daube, J.R.3
Low, P.A.4
-
8
-
-
0023002078
-
Trapping of an open channel blocker at the frog neuromuscular acetylcholine channel
-
Neely A, Lingle CJ. Trapping of an open channel blocker at the frog neuromuscular acetylcholine channel. Biophys J 1986;50:981-986.
-
(1986)
Biophys J
, vol.50
, pp. 981-986
-
-
Neely, A.1
Lingle, C.J.2
-
9
-
-
0025152742
-
Effects of organophosphorus anticholinesterases on nicotinic receptor ion channels at adult mouse muscle endplates
-
Tattersall JEH. Effects of organophosphorus anticholinesterases on nicotinic receptor ion channels at adult mouse muscle endplates. Br J Pharmacol 1990;101:349-357.
-
(1990)
Br J Pharmacol
, vol.101
, pp. 349-357
-
-
Tattersall, J.E.H.1
-
10
-
-
0025845531
-
High-dose fluoxetine: Safety and efficacy in 27 cases
-
Stoll AL, Pope HG, McElroy SM. High-dose fluoxetine: safety and efficacy in 27 cases. J Clin Pharmacol 1991;11:225-226.
-
(1991)
J Clin Pharmacol
, vol.11
, pp. 225-226
-
-
Stoll, A.L.1
Pope, H.G.2
McElroy, S.M.3
|